Sign up to save your podcasts
Or
Share Hepatitis C: Cure, but at What Cost?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Hepatitis C: Cure, but at What Cost?
Dr. Paul Sax considers how the high cost of sofosbuvir, simeprevir, and other potentially curative agents might affect their use in patients with HCV genotype 1 infection.
View all episodes
By MedscapeDr. Paul Sax considers how the high cost of sofosbuvir, simeprevir, and other potentially curative agents might affect their use in patients with HCV genotype 1 infection.